Diabetes, Obesity & Metabolism·2 OctNephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney DiseaseExperiments in miceSurvodutidePaper
ADA Scientific Sessions 2026 Abstract·6 JunSurvodutide: Differentiated GLP-1R and Glucagon Receptor (GCGR) Pharmacology Compared with Endogenous Ligands via Time-Resolved AssaysExperiments in cellsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunSurvodutide Improves Heart Failure with Preserved Ejection Fraction and Dyslipidemia in a Diet-Induced Obese Hamster ModelExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunA GLP-1 Analogue Optimized for cAMP-Biased Signaling Improves Weight Loss in Obese MiceExperiments in animalsInterventionsPaper